Dana Saffel, PharmD, DPh, CGP, FASCP
President and Chief Executive Officer
PharmaCare Strategies, Inc.
T. S. Dharmarajan, MD, FACP, AGSF
Chairman, Department of Medicine
Division of Geriatrics
Our Lady of Mercy Medical Center
Bronx, New York
Michael J. Germain, MD
Medical Director, Renal Transplantation
Western New England Renal and Transplant Associates
Springfield, Massachusetts
Professor of Medicine
Tufts University School of Medicine, Boston,Massachusetts.
Faculty Disclosure
Dana Saffel, PharmD, DPh, CGP
Nothing to disclose.
T. S. Dharmarajan, MD, FACP, AGSF: Ortho Biotech Products, L. P.,
Speakers Bureau.
Michael J. Germain, MD: Ortho Biotech Products, L. P.,
grant/research support,consultant,clinical investigator,speakers bureau;Amgen,Inc.,grant/research support,consultant,clinical
investigator,speakers bureau;Roche Laboratories,Inc.,consultant, clinical investigator.
AdvancMed,LLC:
Nothing to disclose.
Goals and Objectives
- Recommend routine anemia screening for patients
in long-term care settings.
- Develop a protocol for differential diagnosis of
anemia for patients with hemoglobin concentration
lower than 12 g/dL in women or 13 g/dL in men.
- Identify patients for whom erythropoiesis-
stimulating agents are indicated.
- Create a strategic plan for managing the anemia of
chronic kidney disease in long-term care settings.
|
Monograph